2017: President Trump’s Sanctions on Venezuela Resulted in Increased Deaths Due to AIDS

Acquired immunodeficiency syndrome (AIDS) is a chronic condition caused by the human immunodeficiency virus, called HIV. HIV damages the immune system so that the body is less able to fight infection and disease.  There is no cure for HIV/AIDS. 90% of patients with the virus can expect to contract AIDS which is fatal in 8 to 10 years. Medicines (antiviral treatments [ART]) can keep the disease from getting worse.

In 1991, Venezuela began to provide ART as part of a program that served the population free-of-charge.[1] The percentage of HIV-positive people receiving ART reached 60% by 2015[2]. All of the ART medicines were imported. The government provided foreign currency to the National Health Ministry for the purchase of ART which then was distributed to pharmacies and hospitals. The foreign currency came from the sale of oil by Venezuela’s state oil company (PDVSA).  According to UNAIDS, 110,000 people in Venezuela were living with HIV in 2015. [3]  

In 2016, the price of oil declined by 60% which led to a decline of $63 billion in Venezuela’s oil sales. The government sought restructuring of its foreign debt which could put off interest payments and make foreign currency available for imports of medicine and food. On August 24, 2017, US President Trump prohibited US financial institutions from participating in a restructuring of Venezuela’s debt. Venezuela paid $200 million in interest payments in late 2017. Trump prohibited CITGO, a US subsidiary of PDVSA, from sending dividends back to Venezuela. (CITGO had provided $2.5 billion in dividends to PDVSA from 2015 through 2017). Critics pointed to the US sanctions for reducing Venezuela’s resources and reducing its ability to purchase ART. [1]

Due to the reduced availability of foreign currency, no funds were made available to the Health Ministry for ART purchases in 2017 and 2018.[1] Public hospitals had no ART medicines.[4] 10,000 HIV-positive people left Venezuela to seek ART in other countries.[4] Some people bought expensive treatments from foreign sources or on the black market. Many patients increased the intervals between treatments. In 2017-18, the percent of patients receiving ART decreased to 30%.[2] The number of people dying from AIDS increased from 2000/year to 5000.[2]

Nationwide ART access was re-established in 2019 with funding from the World Bank through the Global Fund.  The percent of people receiving ART (60%) and the number of deaths due to AIDS (2K) have returned to the 2015-levels. [2] 1400 HIV-positive people who left Venezuela for treatment returned to the country by 2022.[5]



     

1.Irons, Rebecca, Resistance and the regimen:the Microthanatopolitics of Venezuelan antiretroviral scarcity and HIV drug adherence failures, Social Science & Medicine, October 2024

2. UNAIDS, Venezuela Data, https://www.unaids.org/en/regionscountries/countries/venezuela

3. Lancet,Venezuela’s economic crisis hampers HIV/AIDS Treatment, March 18, 2017

4.New Humanitarian,Leave or Die. The choice confronting HIV-positive Venezuelans, November 5, 2019

5.UNAIDS, Venezuela, 2022

Comments

Popular posts from this blog

The Venezuela Reader - A Blog Focused on Recent History and Venezuela-U.S. Relations